Intravenous immunoglobulin in neonates with rhesus hemolytic disease: A randomized controlled trial

Pediatrics

Volumn 127, Issue 4, 2011, Pages 680-686

  Smits Wintjens, Vivianne E H J ^a   Walther, Frans J ^a   Rath, Mirjam E A ^a   Lindenburg, Irene T M ^a   Te Pas, Arjan B ^a   Kramer, Christine M ^b   Oepkes, Dick ^a   Brand, Anneke ^a   Lopriore, Enrico ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Exchange transfusion; Intravenous immunoglobulin; Phototherapy; Rhesus hemolytic disease of the neonate; Top up red cell transfusion

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN; PLACEBO;

ALLERGIC REACTION; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; HYPOTENSION; INFANT; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; NEWBORN HEMOLYTIC DISEASE; PHOTOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TACHYCARDIA; TREATMENT DURATION; TREATMENT RESPONSE;

BILIRUBIN; BLOOD TRANSFUSION, INTRAUTERINE; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; ERYTHROBLASTOSIS, FETAL; ERYTHROCYTE TRANSFUSION; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; HEMOGLOBINOMETRY; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; NETHERLANDS; PHOTOTHERAPY; PROSPECTIVE STUDIES; RH ISOIMMUNIZATION;

EID: 79953294330     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-3242     Document Type: Article

References (30)

1. Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med. 2008;13(4):265-271
2. Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75(2 pt 2):417-421 (Pubitemid 15172372)
3. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144(5):626-631 (Pubitemid 38594764)
4. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics. 1997;99(5). Available at: www.pediatrics.org/cgi/content/full/113/2/e7
5. Steiner LA, Bizzarro MJ, Ehrenkranz RA, Gallagher PG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007;120(1):27-32 (Pubitemid 47036237)
6. Thayyil S, Milligan DW. Single versus double volume exchange transfusion in jaundiced newborn infants. Cochrane Database Syst Rev. 2006;(4):CD004592
7. Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure: experiences from 1 069 newborns. Acta Paediatr Scand. 1985;74(3): 360-365 (Pubitemid 15034473)
8. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316
9. New HV, Stanworth SJ, Engelfriet CP, et al. Neonatal transfusions. Vox Sang. 2009; 96(1):62-85
10. Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr. 1992;121(1):93-97
11. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2003;88(1):F6-F10 (Pubitemid 36084200)
12. Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gokcay E. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr. 1999;88(2): 216-219 (Pubitemid 29124328)
13. Daǧoǧlu T, Ovali F, Samanci N, Bengisu E. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res. 1995;23(4):264-271
14. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev. 2002; (3):CD003313
15. Oepkes D, Van Kamp IL, Simon MJ, Mesman J, Overbeeke MA, Kanhai HH. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstet Gynecol. 2001;184(5):1015-1020 (Pubitemid 32368125)
16. Smits-Wintjens VE, Steggerda SJ, Oepkes D, et al. Bacillus cereus cerebral abscesses in a term neonate with rhesus hemolytic disease treated with exchange transfusion. J Pediatr Inf Dis. 2010;5(3):277-280
17. Nasseri F, Mamouri GA, Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J. 2006;27(12):1827-1830 (Pubitemid 351863312)
18. Tanyer G, Siklar Z, Dallar Y, Yildirmak Y, Tiras U. Multiple dose IVIg treatment in neonatal immune hemolytic jaundice. J Trop Pediatr. 2001;47(1):50-53 (Pubitemid 32170937)
19. Voto LS, Sexer H, Ferreiro G, et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med. 1995;23(6): 443-451 (Pubitemid 26052734)
20. Kriplani A, Malhotra SB, Mandal K. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Gynecol Obstet Invest. 2007;63(3):176-180 (Pubitemid 46514809)
21. Walsh S, Molloy EJ. Toward evidence based medicine for paediatricians: is intravenous immunoglobulin superior to exchange transfusion in the management of hyperbilirubinaemia in term neonates? Arch Dis Child. 2009;94(9):739-741
22. Kumar A, Teuber SS, Gershwin ME. Intravenous immunoglobulin: striving for appropriate use. Int Arch Allergy Immunol. 2006; 140(3):185-198 (Pubitemid 43883131)
23. Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP. Intravenous immunoglobulin G (IVIg) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med. 2004;16(3):163-166 (Pubitemid 40006903)
24. Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F83-F88 (Pubitemid 46423817)
25. Oepkes D, Adama van SP. Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia. Semin Fetal Neonatal Med. 2007;12(6): 432-438 (Pubitemid 350030914)
26. Egberts J, Van Kamp IL, Kanhai HH, Meerman RH, Giordano PC, Gravenhorst JB. The disappearance of fetal and donor red blood cells in alloimmunised pregnancies: a reappraisal. Br J Obstet Gynaecol. 1997;104(7): 818-824 (Pubitemid 27319459)
27. De Boer I, Zeestraten EC, Lopriore E, Van KI, Kanhai HH, Walther FJ. Pediatric outcome in rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol. 2008;198(1):54
28. Rath ME, Smits-Wintjens VE, Lindenburg I, et al. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions. Vox Sang. 2010;99(1):65-70
29. Santos MC, Sa CA, Gomes SC, Camacho LA, Moreira ME. High-dose intravenous immunoglobulin therapy for hyperbilirubinemia due to Rh hemolytic disease: a randomized clinical trial. Presented at: Pediatric Academic Societies annual meeting; May 1-4, 2010; Vancouver, British Columbia, Canada
30. Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M, Salvia-Roiges MD, Botet- Mussons F, Carbonell-Estrany X. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics. 2010;125(1):139-144